Skip to main content

Does FAD-dependent polyamine oxidase contribute to the metabolism of milacemide?

  • Conference paper
Amine Oxidases and Their Impact on Neurobiology

Part of the book series: Journal of Neural Transmission ((NEURAL SUPPL,volume 32))

  • 98 Accesses

Summary

Milacemide, a secondary amine derivative, was previously demonstrated to be a substrate of MAO-B and to be insensitive to the action of copper-dependent amine oxidases. In the present study, it was investigated whether the FAD-dependent secondary amine metabolizing enzyme polyamine oxidase (PAO), could participate in the metabolism of milacemide. For this purpose, the urinary metabolic pattern of oral 14C-milacemide was determined in rats with and without pretreatment with the irreversible PAO inhibitor MDL 72527 and, for comparison, after inhibition of MAO-B by 1-deprenyl.

While 1-deprenyl was shown to significantly decrease the urinary excretion of glycinamide and of an unknown metabolite (UK1, pretreatment with MDL 72527 did not modify the elimination of milacemide as glycinamide but produced a decrease in UK1 equal to that induced by 1-deprenyl. The percent of the dose of milacemide eliminated as unchanged drug was slightly but significantly increased after PAO inhibition, though considerably less than after 1-deprenyl. These data suggest that milacemide might be a substrate of PAO. If confirmed, this result would constitute the first example of the involvement of the FAD-dependent PAO in drug metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Barrand MA, Callingham BA (1982) Monoamine oxidase activities in brown adipose tissue of the rat: some properties and subcellular distribution. Biochem Pharmacol 31:2177–2184.

    Article  PubMed  CAS  Google Scholar 

  • Bolkenius FN, Bey P, Seiler N (1985) Specific inhibition of polyamine oxidase in vivo is a method for the elucidation of its physiological role. Biochim Biophys Acta 838:69–76.

    Article  PubMed  CAS  Google Scholar 

  • Guffroy C, Fowler CJ, Strolin Benedetti M (1983) The deamination of n-pentylamine by monoamine oxidase and a semicarbazide-sensitive amine oxidase of rat heart. J Pharm Pharmacol 35:416–420.

    Article  PubMed  CAS  Google Scholar 

  • Hölltä E (1977) Oxidation of spermidine and spermine in rat liver: purification and properties of polyamine oxidase. Biochemistry 16:91–100.

    Article  Google Scholar 

  • Janssens de Varebeke P, Cavalier R, David-Remacle M, Youdim MBH (1988) Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase. J Neurochem 50:1011–1016.

    Article  PubMed  CAS  Google Scholar 

  • Janssens de Varebeke P, Pauwels G, Buyse C, David-Remacle M, De Mey J, Roba J, Youdim MBH (1989) The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monamine oxidase B. J Neurochem 53:1109–1116.

    Article  PubMed  CAS  Google Scholar 

  • Seiler N (1987) Inhibition of enzymes oxidizing polyamines. In: McCann PP, Pegg AE, Sjoerdsma A (eds) Inhibition of polyamine metabolism. Academic Press, Orlando, pp 49–77.

    Google Scholar 

  • Seiler N, Bolkenius FN, Knödgen B, Mamont P (1980) Polyamine oxidase in rat tissues. Biochim Biophys Acta 615:480–488.

    PubMed  CAS  Google Scholar 

  • Strolin Benedetti M (1989) Oxidative drug metabolism not cytochrom P-450 dependent. Actual Chim Thér 16:337–356.

    CAS  Google Scholar 

  • Strolin Benedetti M, Sontag N, Boucher T, Kan JP (1981) Aliphatic amines as MAO substrates in the rat: the effect of selective inhibitors on the deamination of n-pentylamine. In: Usdin E, Weiner N, Youdim MBH (eds) Function and regulation of monoamine enzymes. Macmillan, London, pp 527–538.

    Google Scholar 

  • Strolin Benedetti M, Dostert P, Guffroy C, Tipton KF (1983) Partial or total protection from long-acting monoamine oxidase inhibitors by new short-acting MAOIs of type A MD 780515 and type B MD 780236. Mod Probl Pharmacopsychiatry 19:82–104.

    CAS  Google Scholar 

  • Strolin Benedetti M, Marrari P, Moro E, Dostert P, Roncucci R (1988) Do amineoxidases contribute to the metabolism of milacemide?. Pharmacol Res Commun 20 [Suppl] 4:135–136.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag

About this paper

Cite this paper

Strolin Benedetti, M., Cocchiara, G., Colombo, M., Dostert, P. (1990). Does FAD-dependent polyamine oxidase contribute to the metabolism of milacemide?. In: Riederer, P., Youdim, M.B.H. (eds) Amine Oxidases and Their Impact on Neurobiology. Journal of Neural Transmission, vol 32. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9113-2_48

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9113-2_48

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82239-5

  • Online ISBN: 978-3-7091-9113-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics